Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Investigation of Vfend on Scedosporisis

NCT01660334 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01660334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01660334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Investigation of Vfend on Scedosporisis
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
July 31, 2006
Completion date
May 31, 2012
Enrollment
13 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

scedosporium infection